Houston, TX, United States of America

Glen Simmons

This inventor holds 1 USPTO granted patent. Top assignee: William Marsh Rice University. Active years: 2018.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Glen Simmons - Innovator in Biofluid Analysis

Introduction

Glen Simmons is a notable inventor based in Houston, TX (US). He has made significant contributions to the field of biofluid analysis, particularly in point-of-care testing. His innovative work has the potential to enhance medical diagnostics and patient care.

Latest Patents

Glen Simmons holds a patent for "Integrated instrumentation for the analysis of biofluids at the point-of-care." This patent describes the design and function of a bead-based lab-on-a-chip portable analyzer. It is specifically used for analyzing biomarker assay cards in point-of-care testing. His inventive approach aims to streamline the process of medical testing, making it more accessible and efficient.

Career Highlights

Glen Simmons is affiliated with William Marsh Rice University, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and improving healthcare technologies. With 1 patent to his name, he exemplifies the spirit of invention in the academic and medical fields.

Collaborations

Glen has collaborated with esteemed colleagues such as John T. McDevitt and Ahmed Haque. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the realm of biofluid analysis.

Conclusion

Glen Simmons is a pioneering inventor whose work in biofluid analysis is paving the way for advancements in point-of-care testing. His contributions are vital to the future of medical diagnostics and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…